The European Medicines Agency's Review of Elexacaftor/ Tezacaftor/Ivacaftor: Extending Its Use to All People with Cystic Fibrosis Aged 2 Years and Older Who do Not Have Two Class I Cftr Variants
AuthID
P-01A-777
P-01A-777